NO131427B - - Google Patents
Download PDFInfo
- Publication number
- NO131427B NO131427B NO3303/69A NO330369A NO131427B NO 131427 B NO131427 B NO 131427B NO 3303/69 A NO3303/69 A NO 3303/69A NO 330369 A NO330369 A NO 330369A NO 131427 B NO131427 B NO 131427B
- Authority
- NO
- Norway
- Prior art keywords
- pyridine
- solution
- sodium
- transferred
- known per
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- FBPINGSGHKXIQA-UHFFFAOYSA-N 2-amino-3-(2-carboxyethylsulfanyl)propanoic acid Chemical compound OC(=O)C(N)CSCCC(O)=O FBPINGSGHKXIQA-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- 229910052801 chlorine Chemical group 0.000 claims description 2
- 239000011737 fluorine Chemical group 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 210000003979 eosinophil Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010040070 Septic Shock Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 208000005279 Status Asthmaticus Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- -1 compound compound Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO743882A NO131426C (enrdf_load_stackoverflow) | 1968-08-17 | 1974-10-28 | |
NO743883A NO131425C (enrdf_load_stackoverflow) | 1968-08-17 | 1974-10-28 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681793218 DE1793218C3 (de) | 1968-08-17 | 1968-08-17 | Wasserlösliche 21-Hemisulfatalkalimetallverbindungen von 6 a-Fluor- 11 ß, 21-dihydroxy-16 a-methyl- 3,20-dioxo-l,4pregnadienen, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE1902651A DE1902651C3 (de) | 1969-01-15 | 1969-01-15 | Neue Kortikoid-21-monophosphate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE19691920634 DE1920634C3 (de) | 1969-04-19 | 1969-04-19 | Wasserlösliche Kortikoid-21-aminoacylate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO131427B true NO131427B (enrdf_load_stackoverflow) | 1975-02-17 |
NO131427C NO131427C (enrdf_load_stackoverflow) | 1975-05-28 |
Family
ID=27181456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO3303/69A NO131427C (enrdf_load_stackoverflow) | 1968-08-17 | 1969-08-15 |
Country Status (11)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2715853A1 (de) * | 1977-04-06 | 1978-10-19 | Schering Ag | Wasserloesliche kortikoide |
DE2920726A1 (de) * | 1979-05-18 | 1980-11-27 | Schering Ag | Neue kortikoide, ihre herstellung und verwendung |
US4456602A (en) * | 1982-08-23 | 1984-06-26 | The Upjohn Company | Amine containing ester prodrugs of corticosteroids |
US4443440A (en) * | 1982-08-30 | 1984-04-17 | The Upjohn Company | Amine containing ester prodrugs of corticosteroids |
JP6090514B1 (ja) * | 2016-05-18 | 2017-03-08 | 日本ゼオン株式会社 | 重合性化合物の製造方法 |
CN110800738A (zh) * | 2019-11-11 | 2020-02-18 | 福州科理技术开发有限公司 | 厨余垃圾除臭杀虫喷射液及其制造方法 |
-
1969
- 1969-07-21 YU YU1889/69A patent/YU34304B/xx unknown
- 1969-07-23 CH CH1128069A patent/CH527177A/de not_active IP Right Cessation
- 1969-08-01 ES ES370164A patent/ES370164A1/es not_active Expired
- 1969-08-11 IL IL32814A patent/IL32814A/en unknown
- 1969-08-14 BE BE737501D patent/BE737501A/xx unknown
- 1969-08-15 SE SE11408/69A patent/SE352348B/xx unknown
- 1969-08-15 NO NO3303/69A patent/NO131427C/no unknown
- 1969-08-15 BR BR211575/69A patent/BR6911575D0/pt unknown
- 1969-08-18 NL NL6912571A patent/NL6912571A/xx not_active Application Discontinuation
- 1969-08-18 GB GB41152/69A patent/GB1286093A/en not_active Expired
- 1969-08-18 FR FR6928228A patent/FR2015858A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
IL32814A (en) | 1973-06-29 |
YU34304B (en) | 1979-04-30 |
NO131427C (enrdf_load_stackoverflow) | 1975-05-28 |
NL6912571A (enrdf_load_stackoverflow) | 1970-02-19 |
YU188969A (en) | 1978-10-31 |
BR6911575D0 (pt) | 1973-02-13 |
BE737501A (enrdf_load_stackoverflow) | 1970-02-16 |
SE352348B (enrdf_load_stackoverflow) | 1972-12-27 |
FR2015858A1 (enrdf_load_stackoverflow) | 1970-04-30 |
ES370164A1 (es) | 1971-04-01 |
IL32814A0 (en) | 1969-11-12 |
GB1286093A (en) | 1972-08-16 |
CH527177A (de) | 1972-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO131427B (enrdf_load_stackoverflow) | ||
PL98712B1 (pl) | Sposob wytwarzania nowych d-homosteroidow | |
US3488421A (en) | Terpenic esters of glucocorticoids | |
NO137754B (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive steroidforbindelser | |
CH493510A (de) | Verfahren zur Herstellung von neuen Steroidderivaten | |
DE1668658C3 (de) | 16alpha-Methyl verbindungen der Pregnanreihe sowie Verfahren zu deren Herstellung. Ausscheidung aus: 1418390 | |
DE1543005C3 (de) | 4-Alkyl-9beta, lOalpha-Delta hoch 4,6-bzw. -Delta hoch 1,4,6 -steroide der Androstanreihe und Verfahren zu deren Herstellung | |
US3054812A (en) | 20beta, 21-dinitrato-delta4-pregnene-17alpha-ol-3, 11-dione, its production, and method of use | |
US3242169A (en) | 6alpha-dimethylaminomethyl-3-oxo-delta4-steroids and method for producing same | |
DE973365C (de) | Verfahren zur Herstellung von Cortison und Hydrocortison | |
US2476508A (en) | Syphilotherapy agent | |
US3028400A (en) | Nsw steroid thioethers and process | |
US2698854A (en) | Steroid sulfoxides | |
DE1072243B (de) | Verfahren zur Herstellung wasserlöslicher Cortisonderivate | |
US3056810A (en) | 3-thio and 3-mercapto-testosterones | |
US3002981A (en) | Androstene-16-ones | |
DE1593319C (de) | 3 OR 2' Amino thiazol eckige Klammer auf 5", 4' 16,17 eckige Klammer zu ostra 1,3,5 (10), 16 tetraene und Verfahren zu deren Herstellung | |
US2918482A (en) | Process of producing cis-testosterone | |
DE1793218C3 (de) | Wasserlösliche 21-Hemisulfatalkalimetallverbindungen von 6 a-Fluor- 11 ß, 21-dihydroxy-16 a-methyl- 3,20-dioxo-l,4pregnadienen, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DE1233866B (de) | Verfahren zur Herstellung von 1-Methyl-delta 1-5alpha-androsten-17beta-ol-3-on-17-est | |
DE1493072C (de) | Neue 3 (omega Halogenalkoxy) 6 formyl Delta hoch 3,5 pregnadienverbindungen | |
CH473787A (de) | Verfahren zur Herstellung von neuen 9B,10a-Steroiden | |
DE2632745A1 (de) | 1,1'-dithiobis-(formamid-hydrazone) | |
US2894875A (en) | Method of producing the highly purified luteinizing gonadotropic factor | |
DE830642C (de) | Verfahren zur Herstellung von Thioacetalen bzw. Thioenolaethern von 20-Oxopregnanen |